Transcriptomics

Dataset Information

0

Expression data from isolated mouse lung endothelial cells


ABSTRACT: Exaggerated signaling by vascular endothelial growth factor (VEGF) A and its receptor, VEGFR2, in pathologies results in poor vessel function. Still, pharmacological suppression of VEGFA/VEGFR2 may aggravate disease. Delineating VEGFR2 signaling in vivo provides strategies for suppression of specific VEGFR2-induced pathways. Three VEGFR2 tyrosine residues (Y949, Y1212, Y1173) induce downstream signaling. Here, we show that knock-in of phenylalanine to create VEGFR2 Y1212F in C57Bl/6 and FVB mouse strains leads to loss of growth factor receptor bound (GRB)2- and phosphoinositide 3´kinase (PI3K)p85-signaling. C57Bl/6 Vegfr2Y1212F/Y1212F show reduced embryonic endothelial cell (EC) proliferation and partial lethality. FVB Vegfr2Y1212F/Y1212F show reduced postnatal EC proliferation. Reduced EC proliferation in Vegfr2Y1212F/Y1212F explants is rescued by c-Myc overexpression. We conclude that VEGFR2 Y1212 signaling induces activation of extracellular-signal regulated kinase (ERK)1/2 and Akt pathways required for c-Myc-dependent gene regulation, endothelial proliferation and vessel stability. We use microarray to determine the differences in gene expression in endothelial cells between WT or Vegfr2Y1212F/Y1212F mice.

ORGANISM(S): Mus musculus

PROVIDER: GSE136085 | GEO | 2019/08/21

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2015-05-26 | E-GEOD-63283 | biostudies-arrayexpress
2011-06-07 | E-GEOD-28483 | biostudies-arrayexpress
2021-03-29 | GSE147036 | GEO
2011-06-07 | GSE28483 | GEO
2018-11-20 | GSE88896 | GEO
2018-11-20 | GSE88895 | GEO
2018-11-20 | GSE88894 | GEO
2019-07-08 | PXD006503 | Pride
2024-02-01 | GSE253868 | GEO
2022-10-11 | GSE172230 | GEO